Pasithea Therapeutics
KTTA
KTTA
9 hedge funds and large institutions have $1.03M invested in Pasithea Therapeutics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
VF
1
Virtu Financial
New York
|
$0 |
| 2 |
SG
2
StoneX Group
New York
|
$0 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$7K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
KPF
1
K2 Principal Fund
Toronto,
Ontario, Canada
| $620K | 491,797 | – | – |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $201K | 159,844 | +81,705 | +105% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $124K | 98,599 | +78,873 | +400% |
|
|
OWP
4
Old Well Partners
Charlotte,
North Carolina
| $42K | 33,000 | +33,000 | New |
|
5
State Street
Boston,
Massachusetts
| $30K | 23,647 | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $7K | 5,452 | -7,353 | -57% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $7K | 5,659 | +3,405 | +151% |
|
8
JPMorgan Chase & Co
New York
| $1K | 1,000 | – | – |
|
|
VF
9
Virtu Financial
New York
| – | – | -14,571 | Closed |
|
|
SG
10
StoneX Group
New York
| – | – | -12,000 | Closed |
|
|
CFGS
11
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
12
Wells Fargo
San Francisco,
California
| $0 | 111 | +16 | +17% |
|